In 2022, Porton delivers RMB 7 billion revenue and 127% revenue growth. Net profit attributable to shareholders of the listed company increased 283% to RMB 2 billion. New POs of DP CDMO increased by 67% to RMB 119 million, and that of CGT CDMO increased by 25% to RMB 159 million 2023 CAPEX is expected […]
Porton Delivers Strong 2022 Performance With 127% Sales Growth Read More »
Porton Pharma Solutions Ltd. is proud to announce that it has made the top quartile of the S&P Corporate Sustainability Assessment for the first time. On February 28, S&P Global released a new set of S&P Global ESG Scores, where Porton Pharma scored 29 out of 100. The score is above the industry average and
Porton Gets Above-Average S&P Global Environmental, Social, And Governance (ESG) Score Read More »
Porton’s recognition by Roche is a testament to the high-quality service and technical expertise that comes with working with a leading global end-to-end CDMO. Shanghai China (December 16, 2022) – Porton Pharma Solutions (hereinafter referred to as Porton) was recently awarded as a winner of the Roche CDMO Award 2021 in recognition of significant contribution
Porton Pharma Solutions Recognized By Roche Group As A Leading CDMO Service Provider Read More »
The year 2022 is an important milestone for Porton. Despite of the uncertainties of the external environment, we always keep in mind Porton’s mission of “Enabling public’s early access to good medicines” to overcome those challenges and ensure delivery through an agile and stable management system. In the future, we will maintain keen insights and
Porton Reports Strong Interim Results 2022 Read More »
PORTON PHARMA SOLUTIONS LTD., a world leading CDMO (Hereafter PORTON) announces plans to invest into a new state of the Art cGMP/API facility inside, Life Science Park Mengeš, Slovenia currently owned and operated by Lek Pharmaceuticals d.d., part of NOVARTIS group. The signing ceremony held on August in Slovenia PORTON’s manufacturing activity in the Life
Porton Pharma Solutions Ltd. To Expand Operations In Europe Read More »
Expand small and medium-scale CDMO production capacity March 10th, 2022, Shanghai · China – Porton Pharma Solutions Ltd. announced that it is to acquire 100% equity of China Gateway Pharmaceutical Development Co., Ltd. (referred to as “Gateway Pharmaceutical”), a CDMO platform under ChemPartner PharmaTech Co., Ltd. Gateway Pharmaceutical is located at Fengxian District, Shanghai. The
Porton Announced To Acquire China Gateway Pharmaceutical Development Co., Ltd. Read More »
March 1st, 2022, Chongqing · China – Porton Pharma Solutions Ltd. announced an investment of 420 million to expand CDMO Production Capacity of Small Molecule API in Porton Pharma (Jiangxi) Co., Ltd. which is mainly engaged in customized production of APIs, intermediates and starting materials. This expansion project will add 2 production workshops, utilities workshop,
Chongqing China, February 10, 2022–Porton Pharma Solutions Ltd. (Porton) today announced it will expand its API CDMO production capacity with approximately RMB 260 million investment in Changshou site, Chongqing in order to capture growing market demand from our global pharmaceutical clients. There will be around 142.6m³ reactors being installed in the new workshop 301. This
Porton Invests To Expand API CDMO Capacity Read More »
Chongqing · China: On January 16, 2022, Porton Pharma Solutions Ltd. released the “2021 Annual Performance Forecast”. The company expects that revenue and net profit will continue to maintain strongly growth in the year of 2021. 2021 Annual Performance Forecast Revenue YoY Change +45%~50% We expect to achieve revenue of RMB 3,004.22 million to RMB
Porton Expects Strongly Growth In Revenue And Net Profit In 2021 Read More »
Subtitle: Enabling Public’s Early Access to Good Medicines On November 6, 2021, Porton Pharma Solutions Ltd. (hereinafter referred to as Porton, stock code: 300363) and Honeywell (NASDAQ code: HON) held a Signing Ceremony of Strategic Cooperation Agreement at the 4th China International Import Expo. Porton will conduct in-depth cooperation with Honeywell in intelligent manufacturing, striving
Porton Joins Hands with Honeywell to Build the World-Class CDMO Platform Read More »